- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03070639
Enhancing Safe Sleep Practices of Urban Low-Income Mothers
August 21, 2017 updated by: Johns Hopkins Bloomberg School of Public Health
The specific aims of the study are to: 1) evaluate the impact of the safe sleep intervention on parents' knowledge, beliefs, intentions, skills and practices related to creating and maintaining a safe sleep environment for their infants during the first four months of life; 2) describe the characteristics of physician anticipatory guidance about safe sleep and identify physician, patient and parent characteristics associated with coverage of the topic at the well-child visits; and 3) evaluate the dissemination of the B'more for Healthy Babies (BHB)'s safe sleep campaign messages and services among our study participants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This intervention trial uses a randomized controlled design and will be conducted in the Harriet Lane Clinic.
The study conditions are: Standard Care Group (SG), Attention-Matched Control Group that receives a scald burn prevention intervention (CG), and Intervention Group that receives a safe sleep intervention (IG).
Parents or legal guardians will be enrolled during the newborn visit (when the baby is approximately 4-7 days old).
While waiting to be seen for their 2-week well-child visit, the parent will complete the Baseline Interview and be randomized to SG, IG, or CG.
All participants will receive Standard of Care during all of their well-child visits, which will include standard anticipatory guidance delivered by the pediatric resident.
The IG and CG interventions will be delivered in the clinic during the 2-week visit after the baseline survey has been completed.
The first follow-up will be conducted at the home of the parent after completing the 2-week visit, when the baby is approximately 3-6 weeks old.
The second follow-up will be conducted at the home of the parent after the 2-month well-child visit, when the child is approximately 2-4 months of age.
Each home visit consists of an interview covering safe sleep and scald topics, an observation of the baby's sleep environment, and testing the water temperature.
The 2-week and 2-month well-child visits will be audio-recorded, and parent or legal guardians will be asked to complete a Visit Exit Checklist.
Study Type
Interventional
Enrollment (Actual)
214
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Harriet Lane Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult (18 years of age) or emancipated minor.
- Parent or legal guardian of the child.
- Child is receiving care at the Harriet Lane Clinic.
- Child's primary care provider is participating in the study.
- English-speaking.
- Lives in Baltimore City or Baltimore County.
- Not homeless or not living in a shelter or in an established transitional housing facility.
Exclusion Criteria:
- Not an adult or emancipated minor.
- Not the parent or legal guardian of the child.
- Child is not receiving care at the Harriet Lane Clinic.
- Child's primary care provider is not participating in the study.
- Non English-speaker.
- Does not live in Baltimore City or Baltimore County.
- Homeless or living in a shelter or other established transitional housing facility.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard Care Study Condition
The Standard of Care control group will not receive any additional services at the newborn visit.
|
|
|
Active Comparator: Attention-Matched Control Condition
The Attention-Matched Control Condition will include the Scald Prevention Intervention.
|
A health educator will visit participant during their 2-week well visit in the clinic, to deliver a tailored intervention based on practices regarding scald risks in the home.
Participant will also receive a bath thermometer, candy/frying thermometer, and educational resources on scald prevention.
|
|
Experimental: Safe Sleep Intervention Condition
The Intervention Condition will include the Safe Sleep Intervention.
|
A health educator will visit participant during their 2-week well visit in the clinic, to deliver a tailored intervention based on the baby's sleep practices.
Participant will also receive a free pack'n play, sleep sack, and educational resources on safe sleep.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the Effect of a Safe Sleep Intervention on the Safe Sleep Environment of Infants
Time Frame: Follow-up #1 (3-6 weeks)
|
Assessed with a 125-item questionnaire.
|
Follow-up #1 (3-6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the Effect of a Scald Prevention Intervention on Potential Scald Risks in the Home
Time Frame: Follow-up #1 (3-6 weeks)
|
Assessed with a 45-item questionnaire.
|
Follow-up #1 (3-6 weeks)
|
|
Describe Characteristics of Physician Anticipatory Guidance on Safe Sleep and Other Safety Topics
Time Frame: 2-week well-child visit and 2-month well-child visit
|
Assessed with an 11-item coding sheet and transcription file.
|
2-week well-child visit and 2-month well-child visit
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate Dissemination of City Health Department's Safe Sleep Campaign Messages and Services Among Participants
Time Frame: Baseline survey (2 weeks)
|
Assessed with a 13-item questionnaire.
|
Baseline survey (2 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Andrea C Gielen, ScD, ScM, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Burrell TD, McDonald EM, Mahoney P, Musci RJ, Shields W, Gielen A, Solomon BS. Content of Infant Safe Sleep Counseling and Maternal Reported Practices in an Urban Clinic. Acad Pediatr. 2019 Sep-Oct;19(7):801-807. doi: 10.1016/j.acap.2019.06.014. Epub 2019 Jun 26.
- McDonald EM, Davani A, Price A, Mahoney P, Shields W, Musci RJ, Solomon BS, Stuart EA, Gielen AC. Health education intervention promoting infant safe sleep in paediatric primary care: randomised controlled trial. Inj Prev. 2019 Jun;25(3):146-151. doi: 10.1136/injuryprev-2017-042421. Epub 2017 Sep 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
June 1, 2017
Study Registration Dates
First Submitted
February 28, 2017
First Submitted That Met QC Criteria
February 28, 2017
First Posted (Actual)
March 3, 2017
Study Record Updates
Last Update Posted (Actual)
August 22, 2017
Last Update Submitted That Met QC Criteria
August 21, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HD072821
- 1R01HD072821-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sudden Infant Death Syndrome
-
Children's Hospital Medical Center, CincinnatiEvery Child Succeeds; de Cavel Family SIDS FoundationCompletedSudden Infant Death Syndrome (SIDS)United States
-
University of VirginiaNational Center for Research Resources (NCRR); March of DimesCompletedSudden Infant Death SyndromeUnited States
-
Amasya UniversityHealth Institutes of TurkeyCompleted
-
Rachel Moon, MDCompletedSudden Infant Death SyndromeUnited States
-
National Center for Research Resources (NCRR)CompletedSudden Infant Death Syndrome
-
University of Massachusetts, WorcesterBoston University; University of Colorado, Denver; Eunice Kennedy Shriver National... and other collaboratorsNot yet recruitingSUID | Sudden Infant Death Syndrome (SIDS) | Safe Sleep EducationUnited States
-
University of VirginiaBoston University; Washington University School of Medicine; National Institute... and other collaboratorsRecruitingInfant Death | Breastfeeding | Sudden Infant Death Syndrome Without Mention of AutopsyUnited States
-
Eunice Kennedy Shriver National Institute of Child...Yale UniversityCompletedApnea | Sudden Infant Death Syndrome
-
Amasya UniversityNot yet recruitingSudden Infant Death Syndrome | Shaken Baby SyndromeTurkey
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingSudden Infant Death | Sudden Unexplained Infant DeathUnited States
Clinical Trials on Scald Prevention Intervention
-
Emory UniversityNational Institutes of Health (NIH)Completed
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of Alabama at BirminghamCompletedViolence in AdolescenceUnited States
-
Yale UniversityEnrolling by invitation
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
University of ValenciaUnknownAging ProblemsSpain
-
Centre Hospitalier Universitaire VaudoisUnknown
-
Assistance Publique Hopitaux De MarseilleRecruitingCardiomyopathies | Stroke, Ischemic | Heart Failure NYHA Class II | Vascular Disease | Atrial Fibrillation (AF) | Cardiovascular | Hypertension Resistant to Conventional TherapyFrance
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed